[ effectiveness, side effects and acceptability of locally available brand of Clopidogrel [Osvix] as antiplatelet tablet in CABG patients]

ABSTRACT

Background: Platelet activation and aggregation plays an essential role in the formation of coronary artery thrombosis. Nowadays, the Clopidogrel is administered orally as an inhibitor of platelet aggregation. Due to the high price of the original brand of Clopidogrel [Plavix], an Iranian brand of Clopidogrel [Osvix] has been produced